Results 241 to 250 of about 1,648,031 (312)

Association between depression and health care expenditure in middle-aged and older patients with heart disease. [PDF]

PLoS One
You S, Gu X, Sui J, Xiang Z, Gao F.
europepmc   +1 more source

Mobilizing mine lands for biobased decarbonization strategies

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Over 163 000 ha of mine lands in Pennsylvania (PA) have the potential to produce willow as a feedstock for renewable energy generation. Each year these lands could produce between 454 000 and 907 000 dry Mg of willow, which can be a feedstock for bioenergy (i.e., biopower) with carbon capture and sequestration (BECCS) or sustainable aviation ...
Mallory Wahlstrom, Michael Jacobson, Matthew Langholtz, Timothy A. Volk, Ingrid Busch   +4 more
wiley   +1 more source

Where do children get vaccinated in the U.S.? Parental experiences, attitudes, and beliefs about place of vaccination with a focus on pharmacies and schools. [PDF]

Vaccine
Kang Y, Zhang F, Vogt TM.
europepmc   +1 more source

Delivered cost of switchgrass pellets transported from depots to a biorefinery in the Piedmont, USA

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The southeast region of the USA has the potential to be a significant producer of biobased products; however, research is needed to demonstrate the most cost‐effective feedstock delivery system. This study considers a distributed network of five pellet depots to supply feedstock (i.e., switchgrass pellets) for the operation of a hypothetical ...
Jonathan P. Resop, John S. Cundiff, Shahabaddine Sokhansanj   +2 more
wiley   +1 more source

Production of a nutrient enriched biochar: a techno‐economic feasibility analysis

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract A techno‐economic feasibility analysis was conducted for a biomass pyrolysis plant that utilized Eucalyptus to produce fertilizer‐enriched biochar. Key parameters – biomass throughput, fertilizer loading, and selling price – were optimized for financial viability using net present value (NPV), internal rate of return (IRR), return on ...
Brendon Trollip, Ryan David Merckel
wiley   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt, Áine Keogh, Linda Duane, John Ferguson, Anna Hobbins, Brian E. McGuire, Patrick Gillespie, Laurence J. Egan   +7 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Survival Disparities by Health Insurance Coverage Among Patients With Metastatic Cancer.

JAMA Netw Open
Zhao J, Graetz I, Howard D, Yabroff KR, Lipscomb J.   +4 more
europepmc   +1 more source

Correction: Association between long COVID and nonsteroidal anti-inflammatory drug use by patients with acute-phase COVID-19: A nationwide Korea National Health Insurance Service cohort study. [PDF]

PLoS One
PLOS One Staff.
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Health Insurance Payer Status Is Associated With Frailty in a Surgical Patient Population: A Retrospective Case Series. [PDF]

Health Sci Rep
Fenton D, Kent JR, Nordgren R, Siamatu M, Allen A, Gleason LJ, Landi AJ, Huisingh-Scheetz M, Ferguson MK, Madariaga MLL.   +9 more
europepmc   +1 more source